Skip to main content
logo
Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.850
+0.170 (6.34%)
At close: Jun 15, 2026, 4:00 PM EDT
2.820
-0.030 (-1.05%)
After-hours: Jun 15, 2026, 7:56 PM EDT

Sana Biotechnology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-241.99-244.17-266.76-283.26-269.48-355.93
Depreciation & Amortization
11.4912.7515.517.5415.6311.07
Stock-Based Compensation
24.125.4637.6835.5338.3422.36
Other Adjustments
57.372.24-8.39-42.01-82.0861.64
Changes in Accounts Payable
1.13-3.551.381.031.06-0.27
Changes in Accrued Expenses
-2.94-4.74-8.39-1.5210.915.84
Changes in Other Operating Activities
-3.96-1.835.8319.1-4.434.23
Operating Cash Flow
-132.55-143.83-223.15-253.58-290.05-251.05
Capital Expenditures
-1.09-0.94-33.43-20.03-20.88-29.86
Sale of Property, Plant & Equipment
1.431.43----
Purchases of Investments
-91.2-87.29-226.06-157.74-78.69-491.39
Proceeds from Sale of Investments
83.4646.56276.95349.79310.13280.03
Other Investing Activities
------4.57
Investing Cash Flow
-7.4-40.2417.45172.01210.56-245.8
Long-Term Debt Issued
-0.26-0.357.74---
Long-Term Debt Repaid
-0.09-----
Net Long-Term Debt Issued (Repaid)
-0.35-0.357.74---
Issuance of Common Stock
127.98129.08192.0131.654.91631.75
Net Common Stock Issued (Repurchased)
127.98129.08192.0131.654.91631.75
Financing Cash Flow
127.62128.73199.7531.654.91631.75
Net Cash Flow
-12.33-55.33-5.95-49.92-74.58134.9
Free Cash Flow
-133.64-144.77-256.58-273.61-310.93-280.92
Free Cash Flow Per Share
-0.51-0.57-1.11-1.41-1.65-1.69
Levered Free Cash Flow
-237.7-242.82-278.13-267.13-267.19-364.92
Unlevered Free Cash Flow
-243.67-248.62-291.84-277.02-270.27-365.9
SEC Filings: 10-K · 10-Q